Latest news
Loading news…
Calistoga Pharmaceuticals develops therapeutic oral medicines for patients suffering from cancer and inflammatory diseases.
Calistoga Pharmaceuticals was acquired by Gilead Sciences in 2011 for $375M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
3
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Seattle, Washington, United States
Key People at Calistoga Pharmaceuticals
President
CSO
3
professional contacts at Calistoga Pharmaceuticals
Contact execs at Calistoga Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Calistoga Pharmaceuticals
Loading news…
FAQs about Calistoga Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.